FI834413A - Nya kefemfoereningar och foerfarande foer deras framstaellning - Google Patents

Nya kefemfoereningar och foerfarande foer deras framstaellning Download PDF

Info

Publication number
FI834413A
FI834413A FI834413A FI834413A FI834413A FI 834413 A FI834413 A FI 834413A FI 834413 A FI834413 A FI 834413A FI 834413 A FI834413 A FI 834413A FI 834413 A FI834413 A FI 834413A
Authority
FI
Finland
Prior art keywords
framework
new foundation
foundation equipment
equipment
new
Prior art date
Application number
FI834413A
Other languages
English (en)
Finnish (fi)
Other versions
FI834413A0 (fi
Inventor
Takao Takaya
Takashi Masugi
Takashi Ogino
Hisashi Takasugi
Hideaki Yamanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300122A external-priority patent/GB8300122D0/en
Priority claimed from GB838317496A external-priority patent/GB8317496D0/en
Priority claimed from GB838329768A external-priority patent/GB8329768D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI834413A0 publication Critical patent/FI834413A0/fi
Publication of FI834413A publication Critical patent/FI834413A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
FI834413A 1982-12-06 1983-12-02 Nya kefemfoereningar och foerfarande foer deras framstaellning FI834413A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8234755 1982-12-06
GB838300122A GB8300122D0 (en) 1983-01-05 1983-01-05 Cephem compounds
GB838317496A GB8317496D0 (en) 1983-06-28 1983-06-28 Cephem compounds
GB838329768A GB8329768D0 (en) 1983-11-08 1983-11-08 Cephem compounds

Publications (2)

Publication Number Publication Date
FI834413A0 FI834413A0 (fi) 1983-12-02
FI834413A true FI834413A (fi) 1984-06-07

Family

ID=27449416

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834413A FI834413A (fi) 1982-12-06 1983-12-02 Nya kefemfoereningar och foerfarande foer deras framstaellning

Country Status (17)

Country Link
US (2) US4584290A (xx)
EP (1) EP0111281B1 (xx)
JP (1) JPH0639475B2 (xx)
KR (1) KR840007011A (xx)
AU (1) AU2174783A (xx)
CH (1) CH656882A5 (xx)
DE (1) DE3381627D1 (xx)
DK (1) DK554483A (xx)
ES (3) ES527790A0 (xx)
FI (1) FI834413A (xx)
FR (1) FR2537141B1 (xx)
GB (1) GB2139617B (xx)
GR (1) GR79043B (xx)
IT (1) IT1168734B (xx)
NO (1) NO834463L (xx)
OA (1) OA07602A (xx)
PT (1) PT77772B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79043B (xx) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
DE69331576T2 (de) * 1992-09-18 2002-10-17 Otsuka Kagaku K.K., Osaka Cephem-verbindungen, verfarhren zu ihrer herstellung und diese enthaltende medikamente
WO1995025109A1 (fr) * 1994-03-17 1995-09-21 Otsuka Kagaku Kabushiki Kaisha Compose de cephem, procede d'obtention de ce compose et agent antibacterien contenant celui-ci
AU4496896A (en) * 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
US5948774A (en) * 1995-05-29 1999-09-07 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
ES2191759T3 (es) * 1995-07-13 2003-09-16 Koninkl Philips Electronics Nv Metodo y sistema para la repeticion de datos entre agrupamientos logicamente sucesivos.
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
AUPO973297A0 (en) * 1997-10-10 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. New compound
US20050267092A1 (en) * 2002-02-28 2005-12-01 Chang-Seok Lee Novel cephalosporin compounds and process for preparing the same
EP2862569A1 (en) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104177408B (zh) * 2014-09-12 2016-09-07 衡水衡林生物科技有限公司 （z）-2-(5-二氯磷酰氨基-1,2,4-噻二唑-3-基)-2-乙氧亚胺基乙酰氯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148830B (it) * 1979-05-23 1986-12-03 Rhone Poulenc Ind Tiovinil-3 cefalosporine, loro preparazione e composizioni che le contengono
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (xx) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
EP0111281A3 (en) 1985-07-03
JPH0639475B2 (ja) 1994-05-25
JPS59130292A (ja) 1984-07-26
GB2139617B (en) 1986-09-24
GB8331713D0 (en) 1984-01-04
ES534202A0 (es) 1985-06-01
OA07602A (fr) 1985-03-31
AU2174783A (en) 1984-06-14
DE3381627D1 (de) 1990-07-12
US4584290A (en) 1986-04-22
FR2537141B1 (fr) 1987-02-27
DK554483D0 (da) 1983-12-01
ES8506729A1 (es) 1985-07-16
ES527790A0 (es) 1985-07-16
US4719206A (en) 1988-01-12
ES8506730A1 (es) 1985-07-16
CH656882A5 (de) 1986-07-31
EP0111281A2 (en) 1984-06-20
IT1168734B (it) 1987-05-20
IT8324035A0 (it) 1983-12-05
EP0111281B1 (en) 1990-06-06
FI834413A0 (fi) 1983-12-02
PT77772B (en) 1986-04-17
GB2139617A (en) 1984-11-14
NO834463L (no) 1984-06-07
PT77772A (en) 1984-01-01
ES534203A0 (es) 1985-07-16
KR840007011A (ko) 1984-12-04
ES8505690A1 (es) 1985-06-01
GR79043B (xx) 1984-10-02
DK554483A (da) 1984-06-07
FR2537141A1 (fr) 1984-06-08

Similar Documents

Publication Publication Date Title
FI834170A0 (fi) Foerfarande och anordning foer foerpackning medelst vakuum och daervid erhaollen foerpackning
FI874102A0 (fi) Nya kefemfoereningar och foerfarande foer deras framstaellning.
FI834413A0 (fi) Nya kefemfoereningar och foerfarande foer deras framstaellning
FI810058L (fi) Nya dipyridamol-retardationsformer och foerfarande foer deras framstaellning
FI864658A (fi) Nya kefemfoereningar och foerfarande foer deras framstaellning.
FI813971L (fi) Nya pyrimidoner deras framstaellning och deras anvaendning saosom laekemedel
FI832415L (fi) Foerfarande foer framstaellning av en reducerad fettbredning
FI831102L (fi) Nya quinolonfoereningar och framstaellning av dessa
FI790584A (fi) Nya antigenderivat och foerfarande foer framstaellning av desamma
FI822043L (fi) Nya kefemkompositioner och foerfarande foer deras framstaellning
FI803108A (fi) Nya cytostatiskt verkande isocyanursyrafoereningar och foerfarande foer deras framstaellning
FI813934L (fi) Nya fenylalkylaminer deras framstaellning och deras anvaendning saosom laekemedel
FI822632A0 (fi) Nya kefemfoerbindningar och metoder foer deras framstaellning
FI811703L (fi) Nya kinoxalin-2-yl-etenylketoner och foerfarande foer deras framstaellning
FI834666A0 (fi) Foerfarande foer framstaellning av nya aralkyltriazolfoereningar
FI65913B (fi) Foerfarande foer framstaellning av jaern och selen innehaollande spaoraemnespreparat
FI832720A (fi) Nya separerade ketofoereningar och deras separeringsfoerfarande
FI810120L (fi) Nya tioler och foerfarande foer deras framstaellning
FI820526L (fi) Nya ergolinderivat deras framstaellning och farmaceutisk komposition
FI821564A0 (fi) Kombinerad grussorterare och cementblandare
FI812335L (fi) Nya laktamer foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI813992L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI813835L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
FI833156A (fi) Faestanordning foer anvaendning i laettbetong och liknande material
FI833956A (fi) Nya heterocykliska aettikasyror och foerfarande foer deras framstaellning

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD